• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非运动症状负担分级可预测帕金森病患者的认知障碍。

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.

机构信息

Department of Neurosciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.

Parkinson Foundation Centre of Excellence at King's College Hospital, London, UK.

出版信息

Brain Behav. 2021 May;11(5):e02086. doi: 10.1002/brb3.2086. Epub 2021 Mar 1.

DOI:10.1002/brb3.2086
PMID:33645912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8119808/
Abstract

BACKGROUND

Identifying predictors of incident cognitive impairment (CI), one of the most problematic long-term outcomes, in Parkinson's disease (PD) is highly relevant for personalized medicine and prognostic counseling. The Nonmotor Symptoms Scale (NMSS) provides a global clinical assessment of a range of NMS, reflecting NMS burden (NMSB), and thus may assist in the identification of an "at-risk" CI group based on overall NMSB cutoff scores.

METHODS

To investigate whether specific patterns of PD NMS profiles predict incident CI, we performed a retrospective longitudinal study on a convenience sample of 541 nondemented PD patients taking part in the Nonmotor Longitudinal International Study (NILS) cohort, with Mini-Mental State Examination (MMSE), NMSS, and Scales for Outcomes in PD Motor Scale (SCOPA Motor) scores at baseline and last follow-up (mean 3.2 years) being available.

RESULTS

PD patients with incident CI (i.e., MMSE score ≤ 25) at last follow-up (n = 107) had severe overall NMSB level, significantly worse NMSS hallucinations/perceptual problems and higher NMSS attention/memory scores at baseline. Patients with CI also were older and with more advanced disease, but with no differences in disease duration, dopamine replacement therapy, sex, and comorbid depression, anxiety, and sleep disorders.

CONCLUSIONS

Our findings suggest that a comprehensive baseline measure of NMS and in particular hallucinations and perceptual problems assessed with a validated single instrument can be used to predict incident CI in PD. This approach provides a simple, holistic strategy to predict future CI in this population.

摘要

背景

识别帕金森病(PD)中认知障碍(CI)的预测因素至关重要,CI 是最具挑战性的长期预后之一,这对个性化医疗和预后咨询具有重要意义。非运动症状量表(NMSS)提供了一系列非运动症状的全面临床评估,反映了非运动症状负担(NMSB),因此可以根据总体 NMSB 截止分数协助识别“处于风险中”的 CI 群体。

方法

为了研究 PD 非运动症状谱是否存在特定模式可以预测 CI 的发生,我们对参加非运动纵向国际研究(NILS)队列的 541 例非痴呆 PD 患者进行了回顾性纵向研究,这些患者在基线和最后一次随访(平均 3.2 年)时均具有 Mini-Mental State Examination(MMSE)、NMSS 和帕金森病运动量表的结果量表(SCOPA 运动量表)评分。

结果

在最后一次随访时患有 CI(即 MMSE 评分≤25)的 PD 患者(n=107)具有严重的总体 NMSB 水平,在基线时 NMSS 幻觉/知觉问题和 NMSS 注意力/记忆评分显著更差。患有 CI 的患者年龄更大,疾病更严重,但疾病持续时间、多巴胺替代疗法、性别以及合并的抑郁、焦虑和睡眠障碍无差异。

结论

我们的研究结果表明,基线时对 NMS 进行全面的评估,特别是使用经过验证的单一工具评估幻觉和知觉问题,可用于预测 PD 中的 CI 发生。这种方法提供了一种简单、整体的策略,可用于预测该人群的未来 CI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/8119808/f5fb852b7609/BRB3-11-e02086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/8119808/f0285d2e231f/BRB3-11-e02086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/8119808/f5fb852b7609/BRB3-11-e02086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/8119808/f0285d2e231f/BRB3-11-e02086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/8119808/f5fb852b7609/BRB3-11-e02086-g002.jpg

相似文献

1
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.非运动症状负担分级可预测帕金森病患者的认知障碍。
Brain Behav. 2021 May;11(5):e02086. doi: 10.1002/brb3.2086. Epub 2021 Mar 1.
2
Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.养老院帕金森病患者的非运动症状:患病率及其对生活质量的影响。
J Am Geriatr Soc. 2013 Oct;61(10):1714-21. doi: 10.1111/jgs.12458. Epub 2013 Oct 1.
3
Nonmotor symptoms of 820 Taiwanese patients with Parkinson's disease: an exploratory-comparative study.820 例台湾帕金森病患者的非运动症状:一项探索性比较研究。
J Neurol. 2020 May;267(5):1499-1507. doi: 10.1007/s00415-020-09708-4. Epub 2020 Feb 5.
4
Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms.帕金森病非痴呆患者死亡率的预测因素:运动症状与非运动症状
J Geriatr Psychiatry Neurol. 2018 Jan;31(1):19-26. doi: 10.1177/0891988717743589. Epub 2017 Nov 30.
5
The Nonmotor Features of Parkinson's Disease.帕金森病的非运动症状
Int Rev Neurobiol. 2017;132:33-54. doi: 10.1016/bs.irn.2017.02.016. Epub 2017 Apr 4.
6
Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.非痴呆型帕金森病患者日常生活认知活动功能与非运动性负担的相关性。
Neuropsychology. 2020 May;34(4):447-455. doi: 10.1037/neu0000627. Epub 2020 Mar 19.
7
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.帕金森病非运动症状量表心理测量属性的国际研究。
Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.
8
Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease.自主神经症状与帕金森病患者的非自主非运动症状及睡眠问题相关。
Eur Neurol. 2018;80(3-4):193-199. doi: 10.1159/000495797. Epub 2018 Dec 20.
9
Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.便秘与新发帕金森病认知障碍的发展相关:两个国际队列的纵向分析。
J Parkinsons Dis. 2021;11(3):1209-1219. doi: 10.3233/JPD-212570.
10
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.提出一种综合评估帕金森病严重程度的方案,将运动和非运动评估相结合:满足未满足的需求。
PLoS One. 2013;8(2):e57221. doi: 10.1371/journal.pone.0057221. Epub 2013 Feb 27.

引用本文的文献

1
Animal models of chronic obstructive pulmonary disease: a systematic review.慢性阻塞性肺疾病的动物模型:一项系统综述
Front Med (Lausanne). 2024 Oct 24;11:1474870. doi: 10.3389/fmed.2024.1474870. eCollection 2024.
2
Patients with Parkinson's disease demonstrate deficits in visual-spatial memory in the Chinese Visual Retention Test.帕金森病患者在中国视觉保持测验中表现出视觉空间记忆缺陷。
Brain Behav. 2024 Jan;14(1):e3345. doi: 10.1002/brb3.3345.
3
The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis.

本文引用的文献

1
Therapy of Parkinson's Disease Subtypes.帕金森病亚型的治疗。
Neurotherapeutics. 2020 Oct;17(4):1366-1377. doi: 10.1007/s13311-020-00894-7.
2
Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge.帕金森病-轻度认知障碍(PD-MCI):更新知识的有用总结
Front Aging Neurosci. 2019 Nov 8;11:303. doi: 10.3389/fnagi.2019.00303. eCollection 2019.
3
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.检测帕金森病患者的轻度认知障碍:神经心理学测试比较。
精神共病对帕金森病预后的影响:一项系统评价和荟萃分析。
Lancet Reg Health Eur. 2024 Feb 9;39:100870. doi: 10.1016/j.lanepe.2024.100870. eCollection 2024 Apr.
4
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience.长期阿扑吗啡输注治疗晚期帕金森病的安全性和耐受性:一项印度多中心(APO-IND)经验。
Sci Rep. 2023 Oct 31;13(1):18681. doi: 10.1038/s41598-023-46003-4.
5
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的药物和非药物治疗。
Curr Neuropharmacol. 2021;19(12):2233-2249. doi: 10.2174/1570159X19666210517115706.
Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14.
4
Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.帕金森病中的认知障碍:关于未满足需求及维持认知健康未来方向的多学科研讨会报告
NPJ Parkinsons Dis. 2018 Jun 26;4:19. doi: 10.1038/s41531-018-0055-3. eCollection 2018.
5
In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.在 REM 睡眠行为障碍中的病理学的体内分期:一项多模态影像学病例对照研究。
Lancet Neurol. 2018 Jul;17(7):618-628. doi: 10.1016/S1474-4422(18)30162-5. Epub 2018 Jun 1.
6
Risk factors for non-motor symptoms in Parkinson's disease.帕金森病非运动症状的危险因素。
Lancet Neurol. 2018 Jun;17(6):559-568. doi: 10.1016/S1474-4422(18)30127-3. Epub 2018 Apr 23.
7
Comprehensive grading of Parkinson's disease using motor and non-motor assessments: addressing a key unmet need.采用运动和非运动评估对帕金森病进行综合分级:满足一个关键的未满足需求。
Expert Rev Neurother. 2018 Jan;18(1):41-50. doi: 10.1080/14737175.2018.1400383. Epub 2017 Nov 7.
8
Cognitive decline in Parkinson's disease: the complex picture.帕金森病中的认知衰退:复杂情况
NPJ Parkinsons Dis. 2016 Sep 1;2:16018. doi: 10.1038/npjparkd.2016.18. eCollection 2016.
9
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.利用临床基因评分预测帕金森病的认知功能:九个队列的纵向分析
Lancet Neurol. 2017 Aug;16(8):620-629. doi: 10.1016/S1474-4422(17)30122-9. Epub 2017 Jun 16.
10
Personalized medicine in Parkinson's disease: Time to be precise.帕金森病的个性化医疗:是时候做到精准了。
Mov Disord. 2017 Aug;32(8):1147-1154. doi: 10.1002/mds.27027. Epub 2017 Jun 12.